Article Details
Retrieved on: 2022-12-08 13:55:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The REGAL study is a Phase 3 open-label registrational clinical trial for GPS in AML patients who have achieved complete remission following ...
Article found on: www.bakersfield.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here